Celltrion Inc. v. Genentech, Inc. > Summary
Court Case Number IPR2017-01229
Filing Date Mar 31, 2017
Court Patent Trial and Appeal Board
Status Terminated-Denied
Administrative JudgesSheridan K. Snedden, Erica A. Franklin, Jacqueline T. Harlow
Judge Writing the Final DecisionSheridan K. Snedden
Claims Challenged in the Petition: 1, 2, 3, 4, 5, 6, 7, 8, 9
Petitioner
Patent Owner
Petitioner Attorneys
7Celltrion
Attorney Name: Alla Brukman
Cooley LLP
Celltrion
Attorney Name: Susan Krumplitsch
Cooley LLP
Celltrion
Attorney Name: Adam Pivovar
Cooley LLP
Celltrion
Attorney Name: James P. Brogan
Cooley LLP
Celltrion
Attorney Name: Michelle S. Rhyu
Cooley LLP
Celltrion
Attorney Name: Lauren J. Strosnick
Cooley LLP
Celltrion
Attorney Name: Michael Andreeff
The University of Texas M.D. Anderson Cancer Center
Patent Owner Attorneys
7Genentech, Inc
Attorney Name: Lauren N. Drake
Irell & Manella LLP
Genentech, Inc
Attorney Name: David I. Gindler
Irell & Manella LLP
Genentech, Inc
Attorney Name: Yite John Lu
Irell & Manella LLP
Genentech, Inc
Attorney Name: Keith A. Orso
Irell & Manella LLP
Genentech, Inc
Attorney Name: Gary N. Frischling
Irell & Manella LLP
Genentech, Inc
Attorney Name: Michael R. Fleming
Irell & Manella LLP
Genentech, Inc
Attorney Name: David P. Schenkein
Genentech, Inc
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 08206711 | Treatment of chronic lymphocytic leukemia using anti-CD20 antibodies | Jun 26, 2012 |
